SCHEMBL16628820

SCHEMBL16628820

COc1ccc(CCNC(=O)c2nc(N)nc3ccccc23)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.68
KMT2A Q03164 3/20 0.64
MEN1 O00255 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
GAA P10253 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
UBE2I P63279 1/20 0.56
CACNA1B Q00975 1/20 0.56
APBA1 Q02410 1/20 0.56
CTDSP1 Q9GZU7 1/20 0.56
SAE1 Q9UBE0 1/20 0.56
UBA2 Q9UBT2 1/20 0.56
ADORA2A P29274 3/20 0.56
ADORA1 P30542 2/20 0.56
KDM4E B2RXH2 1/20 0.56
ALDH1A1 P00352 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16628794 0.88 ADORA3 (0.58) ADORA3KMT2ASMN1; SMN2ADORA2AADORA1
SCHEMBL3081056 0.88 ADORA2A (0.70) ADORA3SMN1; SMN2ADORA2AADORA1ALDH1A1
SCHEMBL16628795 0.87 ADORA3 (0.66) ADORA3KMT2AMEN1GAASMN1; SMN2
SCHEMBL3087954 0.85 ADORA2A (0.66) ADORA3GAASMN1; SMN2ADORA2AADORA1
SCHEMBL16628751 0.83 CACNA1B (0.56) ADORA3KMT2AMEN1CACNA1BAPBA1
SCHEMBL16628685 0.82 ADORA2A (0.54) ADORA3CYP1A2CYP2D6CYP2C9ADORA2A
SCHEMBL16628837 0.82 ADORA3 (0.58) ADORA3KMT2AMEN1GAASMN1; SMN2
SCHEMBL3093862 0.82 ADORA2A (0.62) ADORA3SMN1; SMN2CACNA1BAPBA1ADORA2A
SCHEMBL3087918 0.80 ADORA3 (0.62) ADORA3CYP1A2CYP2D6GAASMN1; SMN2
SCHEMBL16628733 0.80 ADORA2A (0.59) ADORA3SMN1; SMN2ADORA2AADORA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP claimed